[1] Napetschnig J, Wu H.Molecular basis of NF-κB signaling[J]. Annual Review of Biophysics, 2013, 42:443-468. [2] Oeckinghaus A, Ghosh S.The NF-κB family of transcription factors and its regulation[J]. Cold Spring Harbor Perspectives in Biology, 2009, 1(4):1-15 [3] Niu J, Chang Z, Peng B, et al.Keratinocyte growth factor/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-κB transcription factors[J]. J Biol Chem, 2007, 282(9):6001-6011. [4] Di Prisco G, Iannaccone M, Ianniello F, et al.The neonicotinoid insecticide Clothianidin adversely affects immune signaling in a human cell line[J]. Sci Rep, 2017, 7(1):13446. [5] 包琦, 赵凯, 段子渊. 猪 Btnl5 基因的克隆, 表达分析及对 NF-κB 信号通路的调控作用[J]. 生物技术通报, 2017, 33(6):142-148. [6] 王珺婷, 钟鸣, 刘洁. IL-33 的生物学功能以及对肿瘤作用的研究进展[J]. 生物学杂志, 2018, 35(3):76-79. [7] Thompson AG, Thomas R.Induction of immune tolerance by dendritic cells:implications for preventative and therapeutic immunotherapy of autoimmune disease[J]. Immunology and Cell Biology, 2002, 80(6):509-519. [8] 印翠, 张俊玲, 施志仪, 等. 应用于miRNA 靶标检测的双荧光素酶报告载体的构建及鉴定[J]. 生物技术通报, 2015, 31(12):180-185. [9] Thorne N, Inglese J, Auld DS.Illuminating insights into firefly luciferase and other bioluminescent reporters used in chemical biology[J]. Chemistry & Biology, 2010, 17(6):646-657. [10] Baird AM, Godwin P, Heavey S, et al.4:DHMEQ a novel therapeutic option for the treatment of inflammatory mediated cisplatin resistant non-small cell lung cancer[J]. Lung Cancer, 2015, 87:S2. [11] Kawaguchi M, Yamamoto K, Kanemaru A, et al.Inhibition of nuclear factor-κB signaling suppresses Spint1-deletion-induced tumor susceptibility in the ApcMin/+ model[J]. Oncotarget, 2016, 7(42):68614. [12] Ukaji T, Lin Y, Okada S, et al.Inhibition of MMP-2-mediated cellular invasion by NF-κB inhibitor DHMEQ in 3D culture of breast carcinoma MDA-MB-231 cells:A model for early phase of metastasis[J]. Biochemical and Biophysical Research Communications, 2017, 485(1):76-81. [13] Freitas RHCN, Fraga CAM.NF-κB-IKKβ pathway as a target for drug development:realities, challenges and perspectives[J]. Current Drug Targets, 2018, 19(16):1933-1942. [14] 王晓晨, 吉爱国. NF-κB 信号通路与炎症反应[J]. 生理科学进展, 2014, 45(1):68-71. [15] Hayden MS, Ghosh S.Shared principles in NF-κB signaling[J]. Cell, 2008, 132(3):344-362. [16] Sun SC.The noncanonical NF-κB pathway[J]. Immunological Reviews, 2012, 246(1):125-140. [17] Wang F, Yin J, Lu Z, et al.Limb ischemic preconditioning protects against contrast-induced nephropathy via renalase[J]. EBioMedicine, 2016, 9(1):356-365. |